{"organizations": [], "uuid": "d2e5d56df384e7916d939c62c64b4c54e9e9bd62", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-vtv-therapeutics-says-phase-1b-stu/brief-vtv-therapeutics-says-phase-1b-study-of-ttp399-for-the-treatment-of-type-1-diabetes-completed-idUSFWN1R413B", "country": "US", "domain_rank": 408, "title": "BRIEF-vTv Therapeutics Says Phase 1B Study Of TTP399 For The Treatment Of Type 1 Diabetes Completed", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-22T23:40:00.000+02:00", "replies_count": 0, "uuid": "d2e5d56df384e7916d939c62c64b4c54e9e9bd62"}, "author": "", "url": "https://www.reuters.com/article/brief-vtv-therapeutics-says-phase-1b-stu/brief-vtv-therapeutics-says-phase-1b-study-of-ttp399-for-the-treatment-of-type-1-diabetes-completed-idUSFWN1R413B", "ord_in_thread": 0, "title": "BRIEF-vTv Therapeutics Says Phase 1B Study Of TTP399 For The Treatment Of Type 1 Diabetes Completed", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "treatment of type", "sentiment": "negative"}, {"name": "therapeutics inc", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "diabetes completed reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 22, 2018 / 9:43 PM / Updated 11 minutes ago BRIEF-vTv Therapeutics Says Phase 1B Study Of TTP399 For The Treatment Of Type 1 Diabetes Completed Reuters Staff 1 Min Read   vTv Therapeutics Inc: * VTV THERAPEUTICS ANNOUNCES COMPLETION OF PHASE 1B STUDY EVALUATING TTP399 FOR THE TREATMENT OF TYPE 1 DIABETES Source text for Eikon:  ", "external_links": [], "published": "2018-03-22T23:40:00.000+02:00", "crawled": "2018-03-22T23:57:43.033+02:00", "highlightTitle": ""}